Milgamma NA

Medicinal product

(Invented) name

Milgamma NA

Active substance (s)

Tiamino hidrochloridas/Piridoksino hidrochloridas

Strength

100 mg/50 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A11DB, Vitamin B1 in combination with vitamin B6 and/or vitamin B12

Marketing authorisation holder

Wörwag Pharma GmbH & Co. KG, Vokietija

Date of authorisation

2004-01-13

Date of renewal

2011-07-28

Documents

2518 Milgamma NA inj RPP 2021 10 18.docx

2518 Pakuotės lapelis inj 2021 10 18.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Ampulėje (1 ml tirpalo) yra	1 ml
Tiamino hidrochloridas	100 mg
Piridoksino hidrochloridas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
6613	11679	1011679	ampulė	1 ml N5		Receptinis	LT/1/02/2518/004	Tiekiama	-	-	No	-	-	Download
47996	61819	1061819	ampulė	1 ml N10		Receptinis	LT/1/02/2518/005	Netiekiama	-	-	No	-	-
47997	61820	1061820	ampulė	1 ml N20		Receptinis	LT/1/02/2518/006	Netiekiama	-	-	No	-	-
47998	61821	1061821	ampulė	1 ml N100		Receptinis	LT/1/02/2518/007	Netiekiama	-	-	No	-	-
47999	61822	1061822	ampulė	1 ml N500		Receptinis	LT/1/02/2518/008	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2011-07-28	Perregistruotas
2004-01-13	Registruotas